IV Infusion News
Featured & Company News
We are thrilled to announce the outstanding results from our recent 2024 Q1 Patient Survey Results regarding our nursing services. The average rankings speak volumes about our commitment to excellence.
We are thrilled to announce the outstanding results from our recent 2024 Q1 Patient Survey Results regarding our nursing services. The average rankings speak volumes about our commitment to excellence: Ease of Scheduling: With an impressive average rank of 4.74, we...
Infusion Ventures offers advanced Infusion Nursing services for Advanced Medications, Immunotherapy, Pediatrics, Bleeding Disorders, and Patient Care Management & Planning for our patients throughout New England.
Infusion Ventures offers specialty care when you need it. Infusion nursing services support both on demand coverage as well as scheduled long term infusion therapy and cover the New England area. Clients are treated with consideration, respect, dignity, and...
Visit the Infusion Ventures FAQs page to learn more about infusion therapy, home infusions and other specialty therapy facts.
Infusion Ventures nurses are specially trained and experienced to administer infusion services to patients across all 6 New England states. Visit our FAQ page to learn more about the variety of services we offer. [button...
Since 1993, Infusion Ventures has been there when you need us. Our goal is promoting better health and quality of life for our patients. Learn more at infusionventures.com.
Infusion Ventures is a trusted Specialty Infusion Nursing company infusing state of the art specialty medications. Serving our patients throughout New England, Infusion Ventures collaborates with specialty pharmacies and home IV pharmacies to provide infusion nursing...
Industry News
‘Reverse Vaccination’ May Help Prevent Immune Response | Hemophilia News Today
From Hemophilia News Today: A newly designed platform based on the principle of “reverse vaccination” could be used to prevent the development of an immune response that blocks the effectiveness of treatments for hemophilia and other disorders. Continue reading:...
Advocates Lobby US Congress During Virtual Rare Disease Week
This year’s event featured 250 patient organizations and 367 meetings with Congress. Original Source: Advocates Lobby US Congress During Virtual Rare Disease Week
Statement from NHIA on CMS’ Medicare Payment Rate Increase for Monoclonal Antibody Treatments
Earlier this year, The NHIA (The National Home Infusion Association) issued a statement regarding the decision to increase Medicare payment rates for monoclonal antibody administration. See the original press release below for more details. Alexandria, Va. (May 6,...
COVID-19 Vaccines and Primary Immunodeficiency | CSL Behring
Can PI patients get the vaccine and will it work for them? A doctor who advises the Immune Deficiency Foundation offers her perspective. Source article: COVID-19 Vaccines and Primary Immunodeficiency
Should Parents Be Freaking Out About a New COVID Syndrome Found in Kids?
Doctors have had success using treatment methods that are already widely known to be effective for inflammatory symptoms in children, including intravenous immunoglobulin, or IVIG. Source: Should Parents Be Freaking Out About a New COVID Syndrome Found in Kids?
Examining the Application of Ig in Multiple Disease States | IgNS – Advancing Ig Therapy Practice
Examining the Application of Immunoglobulin in Multiple Disease States: A Review of Evidence Source: Examining the Application of Ig in Multiple Disease States | IgNS - Advancing Ig Therapy Practice
Update on Crohn’s Disease from IG Living
Update on Crohn's Disease from IG Living or [button...
Hemophilia A Patients Using Hemlibra Show Gains in Joint Health, Trial Data Show | Hemophilia News Today
Source: Hemophilia A Patients Using Hemlibra Show Gains in Joint Health, Trial Data Show
Breaking into the Boys Club: Women with Hemophilia
Since hemophilia was discovered, it has been accepted as a male disease. No one questions that a man is struggling with hemophilia. A man with a bleeding disorder living in a developed country is rarely denied access to healthcare. When he receives a diagnosis, he is...
Data: Hemlibra OK in Kids with Hemophilia A Regardless of Inhibitor Status
Preventive treatment with Hemlibra reduces bleeding rates in children younger than 12 with hemophilia type A regardless of inhibitor status, data show. Source: Data: Hemlibra OK in Kids with Hemophilia A Regardless of Inhibitor Status